Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study.
Por:
López-Ferrer A, Vilarrasa E, Armesto S, Santos-Juanes J, Galache C, Carretero G, Sahuquillo A, Salgado-Boquete L, Del Alcázar E, González-Cantero A, Martorell A, Rivera-Díaz R, Mitxelena-Ezeiza J, Mateu A, Belinchón I, Llamas-Velasco M, Riera-Monroig J, Lázaro A, López-Estebaranz JL, Gich I and Puig L
Publicada:
1 nov 2022
Ahead of Print:
15 sep 2022
Resumen:
|